. There is no significant changed. change Q2/2020 Q2/2019 increase (decrease) Sales 269.1 172.5 56.0% Other income 6.8 17.8 -61.6% Cost of sales - 227.7 - 151.2 -50.6% Selling expenses - 6.1 - 5.3 -16.4

end of this year. The COVID-19 pandemic has caused a slight delay in commencing this business. However, as a result of the COVID-19, the Company expects to see a change of consumer behavior toward more

ended 30 September 2020 are as follows: change Q3/2020 Q3/2019 increase (decrease) Sales 277.7 172.6 60.9% Other income 2.5 4.1 -39.9% Cost of sales - 207.6 - 159.6 -30.1% Selling expenses - 7.9 - 4.5

Administrative Expenses 299.41 337.56 443.99 404.19 Total Cost And Expenses 1,077.32 1,099.82 1,325.36 1,551.21 EBITDA 170.41 140.83 130.23 465.98 Depre. & Amor. 35.87 30.07 26.30 17.01 EBIT 134.54 110.75 103.93

1,907.00 Total Cost And Expenses 23,413.56 17,775.76 16,816.15 17,669.21 EBITDA 3,113.32 1,652.09 1,563.44 1,253.84 Depre. & Amor. 589.76 503.03 407.77 387.88 EBIT 2,523.57 1,149.06 1,155.67 865.96 Net

2,186.12 Costs 1,048.10 1,235.50 1,084.30 1,812.28 Selling And Administrative Expenses 139.37 155.92 209.50 214.72 Total Cost And Expenses 1,187.48 1,391.42 1,285.79 1,793.50 EBITDA -39.18 121.05 54.06

39.08 16.70 26.86 Total Revenues 2,136.92 1,848.58 2,072.18 1,967.08 Costs 1,610.00 1,496.81 1,647.83 1,572.51 Selling And Administrative Expenses 148.91 173.84 168.24 228.69 Total Cost And Expenses

446.94 375.88 314.40 Costs 507.85 181.22 157.39 125.04 Selling And Administrative Expenses 267.36 187.22 156.73 148.39 Total Cost And Expenses 775.21 368.44 314.12 273.44 EBITDA 172.30 83.43 63.61 42.16

521.35 481.10 733.33 852.87 Total Cost And Expenses 6,368.46 5,161.42 6,635.39 8,099.69 EBITDA 573.25 203.45 977.92 1,077.01 Depre. & Amor. 586.49 644.61 613.99 608.69 EBIT -13.24 -441.16 363.93 468.32 Net

YTD  2021  2020  Price Change (%) 15.48  15.46  -21.59  Dividend Yield (%) 4.28  3.77  8.21  Payout Ratio 0.40  0.47  0.41  Dividend Policy To pay dividend from the net profit in its financial